Local
This Biotech's Guidance Seemingly Beat Expectations — But A Twist Slammed The Stock
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Source: Investor's Business Daily

Twist Bioscience stock took a header Thursday on artificial intelligence nuances tied to its fiscal year 2027 guidance.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Investor's Business Daily



